• ADDYY
• BP
• CL
• DE40
• FCHI
• HSBC
• LCO
• LHAG
• MAP
• NOVN
• UK100

European stocks lower as investors digest earnings; Germany needs reforms - IMF

• NOVN

Novartis to pay Monte Rosa $150 million upfront to develop a new class of drugs

Novartis agrees to pay Monte Rosa $150 million for drug development rights, significantly enhancing its pipeline while preparing for patent loss on key medications.

• BLUE
• NOVN
• PFE
• VRTX

Why gene therapy for sickle cell is slow to catch on with patients

Zoe Davis, a sickle cell patient, hesitates to try new gene therapies due to their novelty and costs. Many patients face similar challenges, impacting treatment uptake.

• ICAG
• NOVN
• VOWG

Volkswagen, Novartis could surprise in Q3 earnings season, UBS analysts warn

UBS analysts predict surprises in Q3 earnings, flagging Volkswagen and Novartis for potential disappointments while International Airlines Group could exceed expectations amid recovering demand.

• NOVN
• NVS

Jefferies downgrades Novartis despite long-term optimism

Jefferies downgraded Novartis to 'hold', citing near-term caution despite long-term optimism. Delayed product launches and modest growth projections temper short-term expectations, though several key drugs promise future success.

• NESN
• NOVN
• UBSG
• UK100

Pay gap between bosses and ordinary workers widens in Switzerland

The pay gap in Switzerland has widened, with top managers earning 143 times more than lowest-paid workers. Income inequality persists despite rising costs and stagnant wages for others.